Swiss medical technology company Ypsomed has announced plans to establish its first U.S. manufacturing facility in Holly Springs, North Carolina, marking a major step in its global expansion strategy and a significant addition to the region’s growing manufacturing ecosystem.
The company will invest around CHF 200 million (approximately USD 220 million) in the project’s first phase, acquiring a 160,000-square-foot facility with room to expand. The site will begin production by the end of 2027, supplying injection systems for the U.S….
